Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

1.38
Delayed Data
As of Jul 30
 0.00 / 0.00%
Today’s Change
0.61
Today|||52-Week Range
3.50
+64.25%
Year-to-Date
No recent news for Aveo Pharmaceuticals Inc.

Today’s Trading

Previous close1.38
Today’s openn.a.
Day’s range-- - --
Volume100
Average volume (3 months)3,682,729
Market cap$76.0M
Dividend yield--
Data as of 07/30/2015

Growth & Valuation

Earnings growth (last year)+51.90%
Earnings growth (this year)+14.36%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,301.62%
P/E ratioNM
Price/Sales2.42
Price/Book3.50

Competitors

 Today’s
change
Today’s
% change
VCELVericel Corp0.000.00%
EYEGEyeGate Pharmaceutic...-4.75-39.58%
OCRXOcera Therapeutics I...0.000.00%
ORMPOramed Pharmaceutica...-0.14-2.17%
Data as of 9:46am ET, 07/31/2015

Financials

Last reporting dateJuly 31, 2015
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$18.1M
Annual profit (last year)-$52.7M
Net profit margin-291.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael P. Bailey
Chief Financial Officer
Keith S. Ehrlich
Corporate headquarters
Cambridge, Massachusetts

Forecasts